ArticleJournal of neuro-oncology1999

Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1.

M Osmak et al.PubMed ↗Publisher ↗

No numbers read from the abstract.